U.S.
LocationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Merkel
|
Unknown |
9
Strong
|
1 |
HOUSE_OVERSIGHT_024527.jpg
This document is a financial projection memorandum for 'KLC OpCo' (likely Knowledge Learning Corporation) covering the period 2006 to 2011. It details revenue forecasts, projecting growth from $1.55 billion in 2006 to $2.29 billion in 2011, driven by tuition increases, utilization improvements, and the integration of KinderCare. The document outlines operational strategies including center closures in 2006-2007 followed by expansion, and the introduction of additional educational and non-educational products across its U.S. footprint.
HOUSE_OVERSIGHT_024052.jpg
This document appears to be page 41 of a confidential investment memorandum for 'New Leaf,' specifically regarding their third fund, NLV-III. It outlines the 'Medical Devices Investment Strategy,' emphasizing a shift toward later-stage opportunities due to regulatory headwinds in the U.S. and E.U. The document cites specific portfolio successes like Neuronetics, CardioKinetix, and the acquisition of Interlace Medical by Hologix to demonstrate the team's track record.
HOUSE_OVERSIGHT_024051.jpg
This document is a page from a confidential investment memorandum (Control Number 257) produced for the House Oversight Committee. It details the investment strategy for 'NLV-III' (New Leaf Ventures III), focusing on healthcare themes like patient engagement and cost transparency, citing past successes with companies like Audax Health and Truveris. The text outlines the fund's strategy to invest in U.S. private companies, take significant ownership positions, and leverage board participation.
HOUSE_OVERSIGHT_024050.jpg
This document is page 39 of a confidential investment memorandum or fund report stamped by House Oversight. It details specific healthcare investment themes including Care Coordination, Clinical Error Reduction, and Analytics/Data-Driven Personalization, highlighting portfolio companies such as TigerText, ePocrates, iRhythm Technologies, and Treato. The document notes the financial success of ePocrates (acquired for $293 million) and attributes several companies to a fund designated as 'NLV-II'.
HOUSE_OVERSIGHT_024049.jpg
This document appears to be page 38 of a confidential investment memorandum for New Leaf Ventures (specifically fund NLV-III). It outlines the firm's 'Information Convergence' investment strategy, focusing on healthcare technology solutions that address inefficiencies and rising costs in the U.S. healthcare system. It cites 'AwarePoint' (from fund NLV-II) as a case study. The document bears a House Oversight Committee Bates stamp, suggesting it was part of a document production for a congressional investigation, likely related to the financial networks surrounding Jeffrey Epstein, though Epstein is not explicitly named on this specific page.
HOUSE_OVERSIGHT_024042.jpg
This document is page 31 of a confidential investment strategy memorandum for New Leaf Venture Partners' third fund (NLV-III). It outlines the fund's strategy to invest in 24-28 companies, primarily in the U.S., with a 50-60% allocation focus on Biopharmaceuticals, alongside Information Convergence and Medical Devices. The document bears a House Oversight Bates stamp, indicating it was obtained as part of a congressional investigation, likely regarding financial connections.
HOUSE_OVERSIGHT_024030.jpg
This document is a confidential financial report page detailing the performance of two funds, New Leaf Ventures I (NLV-I) and New Leaf Ventures II (NLV-II), as of March 31, 2014. It highlights that both funds are performing in the top quartile according to Cambridge Associates and outlines their capital commitments ($310M and $450M respectively), Internal Rates of Return (IRR), and outperformance against major public indices like the S&P 500. The document bears a House Oversight stamp, suggesting it was obtained during a congressional investigation, likely regarding entities holding these investments.
HOUSE_OVERSIGHT_024018.jpg
This document appears to be a page from a confidential investment prospectus for a fund named 'NLV-III' (likely New Leaf Ventures). It outlines the investment strategy, focusing on biopharmaceutical trends such as FDA 'breakthrough therapy' designations and 'information convergence' in healthcare to reduce costs. The document cites a 2013 editorial by FDA Director Janet Woodcock and notes the evolving commercial models of large pharmaceutical companies.
HOUSE_OVERSIGHT_024017.jpg
This document is page 6 of a confidential investment memorandum for New Leaf Ventures III (NLV-III). It outlines the fund's investment strategy, which focuses primarily on the Biopharmaceutical and Information Convergence sectors in the U.S., with a specific emphasis on targeted therapeutics and molecular mechanisms. The document highlights favorable market conditions and a cooperative regulatory environment with the FDA as key drivers for the fund's potential success.
HOUSE_OVERSIGHT_024016.jpg
This document appears to be page 5 of a confidential investment memorandum for a fund named 'NLV-III' (likely New Leaf Ventures III). It outlines the investment thesis, citing a favorable regulatory environment due to increased FDA approvals and the FDASIA act of 2012, as well as favorable capital market dynamics caused by a contraction in venture capital fundraising which reduces competition for deals. The document bears a House Oversight Committee stamp, indicating it was part of a congressional investigation.
HOUSE_OVERSIGHT_024014.jpg
A confidential financial document, bearing a House Oversight Committee stamp, detailing the historical investment performance of 'New Leaf' and 'Sprout Capital' funds as of March 31, 2014. The document presents a chart comparing fund returns against public indices like the S&P 500 and NASDAQ, highlighting that New Leaf team members invested over $1 billion in Sprout Capital healthcare portfolios with significant returns. The page serves as evidence of financial tracking, likely part of a broader investigation into financial networks.
HOUSE_OVERSIGHT_024012.jpg
This document is an Executive Summary for 'New Leaf Ventures III, L.P.' (NLV-III), a healthcare technology investment fund targeting $375 million in capital commitments. It details the history of the management company, New Leaf Venture Partners, outlining previous funds (NLV-I and NLV-II) and their affiliation with Sprout Group/Credit Suisse. The document lists the Managing Directors and outlines the fund's strategy to invest in 24-28 U.S.-based healthcare companies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production.
HOUSE_OVERSIGHT_024009.jpg
This page contains legal disclaimers for a confidential investment memorandum, likely regarding New Leaf Ventures funds (I, II, and III). It includes standard warnings regarding forward-looking statements, tax liabilities (IRS Circular 230), and investment risks. The document explicitly states that the information is current as of March 31, 2014, and clarifies that Credit Suisse has no affiliation with the funds mentioned and did not prepare the memorandum.
HOUSE_OVERSIGHT_024006.jpg
This document is page 'ii' of a confidential offering memorandum for a fund managed by New Leaf Venture Partners, L.L.C. It contains standard legal disclaimers regarding securities laws and strict confidentiality agreements defining the document as a trade secret. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was obtained during a congressional investigation.
HOUSE_OVERSIGHT_024005.jpg
This document is the 'Statement of Conditions' page (page 'i') from a Confidential Private Placement Memorandum for 'New Leaf Ventures III, L.P.' (NLV-III), a Delaware Limited Partnership. It contains standard legal disclaimers regarding the SEC, the Securities Act of 1933, and the Investment Company Act of 1940, warning investors that the fund is unregistered and high-risk. The document bears a 'CONTROL NUMBER 257 - CONFIDENTIAL' and a 'HOUSE_OVERSIGHT_024005' stamp, indicating it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_013975.jpg
This document appears to be a page from a reference guide or book (resembling 'The 4-Hour Workweek' style advice) regarding international travel logistics. It lists resources for finding housing abroad (Craigslist, Interhome, Rentvillas) and tools for remote computer access and backups (GoToMyPC, WebEx, DropBox, etc.). The document is stamped with a House Oversight footer, indicating it was part of a larger document production.
HOUSE_OVERSIGHT_013973.jpg
This document appears to be a page from a travel resource guide or email listing various websites for cheap airfare, electrical standards, and short-term housing. It includes specific pricing examples (e.g., $300 JFK to London) and personal recommendations from an unidentified author. The document bears the stamp 'HOUSE_OVERSIGHT_013973', indicating it is part of a document production for the House Oversight Committee, likely related to an investigation.
HOUSE_OVERSIGHT_013969.jpg
This document appears to be a page from a book or instructional guide (likely regarding travel, digital nomad living, or lifestyle design) that was included in a House Oversight Committee production (Bates stamped HOUSE_OVERSIGHT_013969). The text provides a timeline and checklist for preparing for long-term travel, including banking advice, storage of vehicles, and finding accommodation upon arrival. It mentions specific locations like Panama and Miami in the context of travel insurance examples, but does not contain specific names or transaction details related to the Epstein investigation on this specific page.
HOUSE_OVERSIGHT_013964.jpg
This document appears to be a page from a book or guide on lifestyle design, minimalism, and long-term travel (likely 'The 4-Hour Workweek' or similar genre). It details the narrator's process of decluttering possessions, selling items on Craigslist, and donating to Goodwill before a 15-month trip, as well as providing a packing list of essentials. The document bears the footer 'HOUSE_OVERSIGHT_013964', indicating it was included as part of a document production to the House Oversight Committee, though the text itself contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_013961.jpg
This document is an excerpt discussing the financial feasibility of international travel compared to domestic living expenses and addresses common fears associated with traveling, particularly for parents. It argues that many reasons for not traveling are merely excuses and provides a case study of a single mother, Jen Errico, who successfully traveled the world with her children by preparing them for emergencies.
HOUSE_OVERSIGHT_013937.jpg
This document appears to be a page from a book or resource guide (likely 'The 4-Hour Workweek' by Tim Ferriss) included in House Oversight evidence files (Bates stamp 013937). It lists resources for product distribution and celebrity endorsements, including specific websites and brokers like Jack King. It also includes a testimonial from 'Ken D.' about domestic outsourcing to family members and a fragment of a message addressing 'Tim' regarding Weebly.com.
HOUSE_OVERSIGHT_013914.jpg
This document, stamped 'HOUSE_OVERSIGHT_013914', appears to be a page of 'Tools and Tricks' for web development and marketing, likely authored by Timothy Ferriss (evidenced by references to his website and blog). It lists resources such as The PX Method, Weebly, WordPress, and Wufoo, providing anecdotal advice on how to use them for quick website creation and testing business ideas. The document discusses setting up a fundraiser in Slovakia that outperformed a Stephen Colbert initiative.
HOUSE_OVERSIGHT_013911.jpg
This document appears to be a page from a book or guide on digital marketing and e-commerce (likely 'The 4-Hour Workweek' or similar genre), detailing A/B testing strategies using Google AdWords. It outlines specific case studies involving individuals named Sherwood and Johanna who are testing markets for sailor shirts and yoga DVDs respectively. The page bears a 'HOUSE_OVERSIGHT_013911' stamp, indicating it was included in a document production to the House Oversight Committee, though the text itself contains no direct reference to Jeffrey Epstein or criminal activity.
HOUSE_OVERSIGHT_013910.jpg
This document appears to be a page from a business advice book (resembling Tim Ferriss's 'The 4-Hour Workweek') labeled with a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_013910). It details a case study of two individuals, Sherwood and Johanna, testing micro-business concepts ('dry testing') using tools like eBay, Weebly, Wufoo, and Google Adwords to gauge market interest before stocking products. There is no direct mention of Jeffrey Epstein or criminal activity in the text itself; it appears to be incidental material included in a larger document production.
HOUSE_OVERSIGHT_013909.jpg
The document is a page from an educational business text or book (likely 'The 4-Hour Workweek' by Tim Ferriss) discussing product testing and market validation. It details two hypothetical case studies: 'Sherwood' importing French sailor shirts to NYC, and 'Johanna' creating yoga DVDs for rock climbers, outlining their cost structures and pricing. It instructs readers on using tools like Google Adwords Keyword Tool and SEOBook for competitive analysis. The document bears the Bates stamp HOUSE_OVERSIGHT_013909.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity